Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway.
Oyagbemi AA, Omobowale TO, Adejumobi OA, Owolabi AM, Ogunpolu BS, Falayi OO, Hassan FO, Ogunmiluyi IO, Asenuga ER, Ola-Davies OE, Soetan KO, Saba AB, Adedapo AA, Nkadimeng SM, McGaw LJ, Oguntibeju OO, Yakubu MA.
Oyagbemi AA, et al. Among authors: oguntibeju oo.
Eur J Pharmacol. 2020 Aug 5;880:173142. doi: 10.1016/j.ejphar.2020.173142. Epub 2020 May 16.
Eur J Pharmacol. 2020.
PMID: 32422184